leadf
logo-loader
viewInnoCan Pharma

Innocan Pharma received U.S. FDA approval for their over the counter CBD pain relief line

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the United States for their patent-pending CBD Relief &GO pain relief collection.

Bincovich talks about the collection and when they would like to have it in stores and online. She also discussed the latest on their research into Covid-19.

Quick facts: InnoCan Pharma

Price: 0.42 CAD

CSE:INNO
Market: CSE
Market Cap: $73.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Snowline Gold looking to unlock potential of Einarson and Rouge projects in...

Snowline Gold (CSE: SGD) CEO Nikolas Matysek joined Steve Darling from Proactive to share more details about the company that will begin trading soon on the CSE under the ticker SGD. Matysek talks about that and also about the formation of the company. Matysek also shared with Proactive about...

35 minutes ago

2 min read